Document:

Exhibit 10.4

 

Second Supplement to the Employment Agreement of Dr. Yiftach Roth

 

At the General Meeting of Shareholders of Brainsway Ltd. (the “Company”) that took place on April 5, 2011, it was resolved to approve an amendment to the terms of employment of Dr. Yiftach Roth, one of the Company’s directors, as the Company’s R&D manager, so that the employment agreement between Dr. Roth and the Company’s wholly-owned subsidiary, Brain Research and Development Services Ltd., shall be extended indefinitely, with each side being entitled to terminate the agreement upon 180 days prior written. All of the other terms of such employment agreement will remain unmodified.

 

Brainsway Ltd.

Brain Research and Development Services Ltd.

 

	
/s/ Uzi Sofer
    	
 
    	
/s/ Dr. Yiftach Roth
    
	
By: Uzi Sofer, CEO
    	
 
    	
Dr. Yiftach Roth
    

 

 

Supplement to the Employment Agreement of Dr. Yiftach Roth

 

In the General Meeting dated May 25, 2009, it was resolved to approve the amendment in the terms of employment of Mr. Yiftach Roth, one of the Company’s directors and a holder of controlling interest in the Company, as the Company’s R&D manager, so that beginning as of April 2009, Dr. Roth will be entitled to receive a gross monthly salary of NIS 20,000, instead of his current monthly salary in a gross amount of NIS 13,453. All of the other terms of the Employment Agreement between Dr. Roth and the Company will remain unmodified.

 

In addition, it was resolved to approve a bonus payment to Mr. Yiftach Roth, one of the Company’s directors and a holder of controlling interest in the Company, for the year 2008, in a total amount of NIS 100,000 (cost to the Company), due to the Company’s achievements in the product development field, including the coils required for the performance of the Company’s clinical trails.

 

Brain Research and Development Services Ltd.

 

	
/s/ Uzi Sofer
    	
 
    	
/s/ Dr. Yiftach Roth
    
	
By: Uzi Sofer, CEO
    	
 
    	
Dr. Yiftach Roth
    

 

 

First Amendment to the Employment Agreement

 

That was made and signed on May 9, 2006

 

 

Between:                                             Brain Research and Development Services Ltd.

Of 15 HaRechavim Street, Jerusalem

(hereafter: ‘the company’)

 

Of the one part;

 

And between        Dr Yiftach Roth

I.D. 024698631

Address: Rehelim, Efraim

(hereafter: ‘the employee’)

 

Of the other part;

 

Whereas                                                                                              the parties entered into an employment agreement on April 3, 2006 (hereafter: ‘the employment agreement’).

 

And whereas                                                                        the parties wish to change some of the terms of the employment agreement pursuant to what is stated below.

 

Wherefore it has been agreed as follows:

 

1.                                      The employment agreement shall come into effect from the date of the commencement of the employment as determined in the employment agreement and shall remain in force until five years have passed from that date, unless it is cancelled by one of the parties pursuant to clause 1 of the employment agreement.

 

2.                                      The provisions of this amendment override any conflicting provision in the employment agreement.

 

In witness whereof the parties have signed below:

 

	
Brain Research and Development Services Ltd.
    	
 
    	
The employee
    
	
By ( - )
    	
/s/ Uzi Sofer
    	
 
    	
/s/ Yiftach Roth
    
	
Position: CEO
    	
 
    	
 
    
				

 

Brain Research and Development Services Ltd.

Private company 513443788

 

 

Employment Agreement

 

That was made and signed on April 3, 2006

 

Between:                                             Brain Research and Development Services Ltd.

Of 15 HaRechavim Street, Jerusalem

(each of the companies hereafter: ‘the company’)

 

Of the one part;

 

And between        Dr Yiftach Roth

I.D. 024698631

Address: Rehelim, Mobile Post Efraim

(hereafter: ‘the employee’)

 

Of the other part;

 

Whereas                                                                                              the employee have provided the company and/or Brainsway Inc., the company that controls the company (hereafter: ‘the holding company’) services up to the date of the commencement of the employment, as defined below, and in return for these services he received payment from the company, in return for which he produced a tax invoice.

 

And whereas                                                                        the company is interested in continuing to receive services from the employee, and the employee is interested in continuing to provide services to the company, and both of them are interested in regulating the terms for the provision of the services as aforesaid by way of employment by the company, all of which pursuant to the terms and provisions of this employment agreement (‘the agreement’).

 

Wherefore it is agreed as follows:

 

1.                                      The employment

 

1.1                               The employee’s employment shall begin on May 1, 2006 (‘the date of commencement of the employment’). The employee shall be employed on a part time basis of forty hours a week. The employee shall be employed in the capacity of a physicist or in any other capacity on a similar standard, as shall be required by the company. The employee undertakes to carry out his undertakings and duties that will be imposed on him by the company from time to time. The employee shall be subordinate to the CEO, who shall act as the direct supervisor of the employee.

 

1.2                               The work shall be performed on Sundays to Thursdays, during the work hours defined in the law. The weekly rest day of the employee shall be Saturday.

 

 

1.3                               The employee hereby agrees that the company has a right, at its sole and absolute discretion, to reduce the scope of the employee’s employment, and consequently also the consideration that is payable for it pursuant to this agreement proportionately. The employee hereby waives any claim of a significant worsening of the work conditions as a result of a reduction in the scope of employment by the company as stated in this clause.

 

1.4                               The employee undertakes to devote all of his time, attention, ability and energy exclusively to carrying out his duties in the company, and he undertakes not to enter into an agreement, whether as an employee or in another way, with any business, commercial and/or professional activity, whether for payment or not, during the period of his employment, including after the hours of the work, at weekends and/or during any vacation period, without the prior written consent of the company. In order to remove doubt, it is hereby clarified that the provisions of this clause shall not derogate from the undertakings of the employee as described in appendix B that is attached hereto.

 

1.5                               Each of the parties shall be entitled to cancel this agreement at any time by giving thirty (30) days’ notice in writing (hereafter — ‘the notice period’).

 

1.6                               Notwithstanding the aforesaid, the company shall be entitled to terminate the employee’s employment immediately or to shorten the duration of the notice period, whether it is given by the company or it is given by the employee, provided that in such a case the employee shall be entitled to compensation in an amount equal to his basic salary as stated in appendix A, as if he were employed by the company until the end of the notice period as stated in clause 1.4 above.

 

1.7                               Should the employee resign without complying with the duty of giving notice, the employer may deduct from any amount payable to the employee, as pre-agreed compensation, an amount equal to the ordinary salary that the employee would have received for the notice period during which he did not work. This shall not derogate from the company’s right, instead of the agreement compensation, to sue the employee for the damage that it suffered de facto as a result of the employee not carrying out his obligation to give notice.

 

1.8                               Notwithstanding the aforesaid, and without derogating from its rights pursuant to this agreement, the company shall be entitled to terminate the employee’s employment without any need for giving notice and without derogating from any relief to which the company is entitled pursuant to any law and/or agreement, if one or more of the following incidents occurs: (1) the employee embezzled the company’s money; or (2) the employee committed a fundamental breach of this agreement; or (3) the employee committed or was involved in an act, deed or omission, which constitutes a breach of faith to the company; or (4) the employee committed a disciplinary infraction; or (5) the employee’s conduct caused serious damage to the company; or (6) the employee was convicted of a criminal offence; or (7) the employee is not capable of carrying out his duties in the company for a period exceeding ninety (90) continuous days. Returning to work for periods that are shorter than fifteen (15) continuous days shall not interrupt the period of the aforesaid ninety (90) days.

 

2

 

1.9                               The employee shall not have a right of lien on the company’s assets, equipment or any other material, including information and confidential information as defined in appendix B of this agreement (hereafter: ‘the company’s equipment’) that is in his possession. The employee shall return to the company all of the company’s equipment that is in his possession no later than the date on which the employment relationship is terminated and also when he goes on holiday for more than 30 days (including paternity leave, or leave in lieu of notice), before going on such leave, or within seven days of the date on which he receives a demand from the company to do so.

 

2.                                      Consideration

 

As consideration for his employment in the company and for complying with the provisions of this agreement, and subject to what is stated in this agreement, including what is stated in its appendices, the employee shall be entitled to salary, terms and benefits as set out in appendix A that is attached hereto.

 

3.                                      Confidentiality, non-competition and ownership of inventions

 

At the same time as he signs this agreement, the employee shall sign an undertaking to the company with regard to confidentiality, non-competition and rights in inventions in favor of the company and any subsidiary or holding company of the company, which is attached hereto as appendix B.

 

4.                                      Representations and undertakings

 

The employee declares and undertakes as follows:

 

4.1                               That he does not have, nor did he have in the past, any claim against the company for providing services to the company before the date of the commencement of the employment and that he makes an informed and irrevocable waiver of any contention and/or claim against the company based on his employment with the company and/or providing services to the company prior to the date of this agreement.

 

4.2                               That he is not bound by undertakings or any other agreements whatsoever that prevent him from making an undertaking in accordance with the provisions of this agreement and from acting in accordance herewith.

 

4.3                               That to the best of his knowledge he is not in breach of any rights and/or undertakings to his former employer.

 

3

 

4.4                               That he has the ability, the skills and the knowledge that are required for the purpose of carrying out the job in accordance with the provisions of this agreement.

 

4.5                               That he will notify the company, immediately and without delay, of any matter or issue in which he and/or his close family have and/or may have a personal interest and/or with regard to which there may be a conflict of interests with his duties and work for the company.

 

4.6                               That he shall not receive any payment and/or other benefit from any third party directly or indirectly with regard to his work in the company. If the employee breaches this clause, then without derogating from the rights of the company pursuant to any agreement or pursuant to law, the amount and/or benefit as aforesaid shall be the property of the company and shall be transferred to it, and the company shall also be entitled to deduct that amount or the value of the benefit from any amount due to the employee from it.

 

4.7                               That within the framework of carrying out his job in the company he shall not act and/or shall not make any representation and/or shall not give any undertaking on behalf of the company and/or shall not take upon himself any undertaking and/or shall not give any guarantee on behalf of the company unless he has prior, written and express instructions from the company and/or its directors and/or his superiors.

 

4.8                               That he agrees and confirms that from time to time he may be required to travel and stay abroad within the framework of his job.

 

4.9                               That in exceptional cases in which there will be a need for this, pursuant to a decision of the company management, the employee will participate in a lie detector (polygraph) test.

 

4.10                        That he undertakes to make use of the company’s equipment and its resources solely for the purpose of carrying out his work and within the framework of his job and that he knows and agrees that the company may make checks on the premises of the company’s offices and in the company’s computers, including e-mail messages and the manner of using the Internet, and the content of all of the aforesaid. In order to remove doubt, it is hereby clarified that the results of the test will be the sole property of the company.

 

4.11                        That in any case of a cancellation of this agreement for any reason, the employee will cooperate with the company and do his best to assist in an orderly transfer of his job in the company and an orderly transition between him and the person designated to replace him in the job.

 

4

 

5.                                      General provisions

 

5.1                               This agreement and all of its appendices that are attached hereto constitute the full agreement between the parties hereto and they override any agreements, proposals, understandings and previous arrangements, whether oral or in writing, if any of these were actually made between the parties with regard to the subject of this agreement.

 

5.2                               Any change and/or addition to this agreement shall bind the parties to the agreement and shall be valid vis-à-vis the parties only if they are in writing and are signed by the parties.

 

5.3                               This agreement shall be governed by Israeli law and shall be interpreted in accordance therewith. The Tel-Aviv Regional Labor Court shall have sole and exclusive jurisdiction with regard to any matter arising from this agreement or relating to this agreement.

 

5.4                               The invalidity and/or cancellation and/or voiding of any of the provisions of this agreement and its appendices shall not derogate from the full validity of any other provisions of the agreement and its appendices.

 

5.5                               The employee confirms and declares that he has thoroughly read and understood all of the provisions of the agreement and its appendices, that these provisions are acceptable to him without reservation and that he is signing the agreement and its appendices freely and voluntarily.

 

5.6                               Any notice should be sent by one party to the other at the address of the party that is stipulated in the preamble to this agreement or any other address of which a party gives notice pursuant to the provisions of this agreement, by registered mail or by hand, and any notice that is sent by registered mail shall be deemed to have been received by the addressee four business days after it is delivered to the post office, and if it is delivered by hand, at the time of delivery, provided that confirmation of delivery is obtained.

 

In witness whereof the parties have signed below:

 

	
Brain Research and Development   Services Ltd.
    	
 
    	
The employee
    
	
By: 
    	
/s/ Uzi Sofer
    	
 
    	
/s/ Yiftach Roth
    
	
Position: CEO
    	
 
    	
 
    
				

 

Brain Research and Development Services Ltd.

Private company 513443788

 

5

 

Appendix A — Consideration

 

1.Salary

 

For his full time work for the company, the employee shall be entitled to a gross monthly salary in an amount of NIS 13,453 (‘the basic salary’).

 

The employee’s basic salary includes a salary component as a payment for his work in normal hours that is equal to 80% of the basic salary and a payment of a work component for overtime which is estimated and equal to 20% of the basic salary. In order to remove doubt, this is not an additional salary component but the basic salary includes the two aforesaid components and constitutes the amount of the consideration to which the employee is entitled pursuant to the Work and Rest Hours Law, 5711-1951.

 

The company will assess the employee’s performance and the company’s performance once a year and it will decide at its sole discretion whether to increase the employee’s basic salary, and if so, by what percentage or amount.

 

2.                                      Insurance policies

 

Subject to the guidelines that will be determined from time to time by the Income Tax Commission, and pursuant to the maximum amount deductible, the company will insure the employee in a ‘managers’ insurance policy’ (hereafter: ‘managers’ insurance’) and will make the following provisions: (1) the company will pay an amount equal to 5% of the employee’s basic salary into a managers’ insurance policy for the employee (hereafter in this clause — ‘the company’s share’), and it shall deduct 5% of the employee’s basic salary (hereafter in this clause — ‘the employee’s share’) and it shall pay this amount in favor of the managers’ insurance policy for the employee (the division of the components of the managers’ insurance into savings and risk shall be determined at the discretion of the employee); and (2) the company shall pay a sum equal to 81/3% of the employee’s basic salary into a severance pay fund.

 

The employee hereby instructs the company to transfer to the managers’ insurance policy the amounts that constitute the employee’s and the employer’s shares out of each payment of monthly salary. To remove doubt, if the employee accumulates an aggregate amount in the fund that exceeds the maximum amount stipulated in an Income Tax Order, the surplus amount shall be regarded as income for tax purposes.

 

3.                                      Release of funds

 

3.1                               Without derogating from the company’s right under any law and/or this agreement, the managers’ insurance policy shall be transferred to the employee, subject to the applicable law and subject to the performance of all of the employee’s undertakings to the company when the employee’s employment is terminated for any reason, excluding in circumstances where the employment is terminated as stated in clause 1.7 of the agreement.

 

6

 

3.2                               It is hereby clarified that pursuant to section 14 of the Severance Pay Law, 5723-1963 (hereafter in this clause — ‘the law’) and the general approval regarding employers’ payments to a pension fund and an insurance fund in lieu of severance pay, which is attached to this agreement (hereafter — ‘the approval’), the amount that will be accumulated for the employee in the insurance policy during his employment for the company until the date on which his employment with it is terminated shall replace severance pay.

 

Pursuant to the terms of the approval, the employer hereby waives any right that he may have to a reimbursement of the money from his payments, unless the employee’s right to severance pay is denied subject to the circumstances described in this agreement and sections 16 and 17 of the law, to the extent that it is denied or the employee withdraws money from the pension fund or from the insurance fund without there being a qualifying event; for this purpose, ‘qualifying event’ — death, disability or retirement at the age of sixty or more.

 

4.                                      Vacation, sick pay and holiday pay

 

Subject to the provisions of the Annual Vacation Law, 5711-1951 (‘the Annual Vacation Law’), the employee shall be entitled to a twelve (12) work day vacation for each twelve (12) month period of his employment, and provided that such vacation may be credited to the employee only for the following two years. If the employee does not use the number of vacation days to which he is entitled during a work year, the employee shall be entitled to redeem the vacation days that he did not use pursuant to the provisions of the Annual Vacation Law. It is clarified that the vacation dates shall be determined by the company by arrangement with the employee.

 

The employee shall be entitled to payment of sick pay and holiday pay according to law.

 

The dates of leaving for vacation shall be determined by the company in accordance with its possibilities and needs, and when it is possible, while taking into account the employee’s wishes. The company shall be entitled to introduce a standard annual vacation for all or some of its employees, with regard to some or all of the vacation entitlement, as it shall see fit.

 

5.                                      Options

 

Subject to the resolutions of the board of directors of the company (hereafter: ‘the board of directors’) and/or the company’s options and bonuses committee, at its sole discretion, and subject to the terms of the options plan and the agreement to grant options that were approved and/or will be approved for this purpose from time to time by the board of directors at its sole discretion, which will include the terms regarding the options, including the exercise date and price, the blocking and unblocking thereof, and all the other conditions and terms regarding the options, the employee shall be entitled to 40,000 options to receive 40,000 ordinary shares of the company with a value of US $ 0.01 each (hereafter: ‘the options’).

 

7

 

Any tax liability with regard to the options (including with regard to the grant, exercise, sale of the options or the shares that are received when they are exercised) shall be payable solely by the employee.

 

6.                                      Business expenses

 

The company shall reimburse the employee for accepted and required business expenses that the employee shall actually incur on behalf of the company and in its stead, pursuant to the company policy as shall be determined by the company from time to time.

 

7.                                      Taxes

 

The company shall deduct at source or debit the employee for taxes and/or other compulsory payments as required by law with regard to or deriving from the consideration payable to the employee and/or received by him with regard to all of the bonuses to which the employee is entitled or may be entitled.

 

Brain Research and Development Services Ltd.

Private co. 513443788

 

8

 

Appendix B — Letter of undertaking

 

Whereas Brain Research and Development Services Ltd. (hereafter: Brain Research and Development Services Ltd. and each of its subsidiaries, holding companies and affiliates — ‘the company’) is interested in employing the employee, subject to making this undertaking (hereafter: ‘the undertaking’);

 

And whereas Dr. Yiftach Roth, holder of ID no. 024698631, of Rehelim Street, [city] Mobile Post Efraim (hereafter — ‘the employee’), is interested in entering into the aforesaid terms of employment;

 

Wherefore, the employee declares and undertakes to the company as follows:

 

1.Confidential information

 

The employee recognizes that he will have access to confidential information and to information concerning the activities of the company and technologies relating to the company, research and development of products, patents, copyrights, commercial secrets, customers (including customer lists), marketing plans, strategies, forecasts, commercial secrets, results of tests, examinations and experiments, formulae, processes, information, knowledge, improvements, inventions, techniques and products (existing or planned). Such information in any form whatsoever, whether in a document, letter, orally, on a computer or on magnetic media shall be regarded as ‘confidential information.’

 

The employee shall not disclose during the period of his employment with the company or at any time after the end of the period of his employment, for any reason, to any person, corporation, partnership or other entity, any confidential information whether orally, in writing or in any other way, that came into the possession of the employee or was brought to his attention during the period of his employment with the company (including the processes and the technologies that are being used or that will be used by the company in its business, the methods and results of the company’s research, technical or financial information, the employee’s terms of employment and those of the other employees of the company or any other information regarding the company’s business or any information with regard to the company’s customers), unless he receives the prior written consent of the company.

 

2.                                      Confidential information shall be regarded as including all confidential information that was delivered by, for or on behalf of the company, irrespective of its form, except for information that the employee can prove entered the public domain other than as a result of a breach of this undertaking by the employee.

 

3.                                      The employee agrees that all of the memoranda, books, records, lists (which are included on any type of media or in any form), records, formulae, specifications, lists and any other document that was prepared, assembled, processed, received, held or used by the employee during his employment with the company, with regard to any stage of the company’s business or its commercial secrets (hereafter: ‘the materials’), shall be the sole property of the company and shall be transferred by the employee to the company when the period of his employment is terminated or at any time previously or otherwise at the company’s demand, without the employee keeping any copies of the aforesaid and without the employee having a right of lien over them.

 

9

 

4.                                      Unfair competition and prohibited inducement

 

The employee agrees that the terms of this undertaking are reasonable and necessary for the lawful protection of the company’s confidential information, its property (including intellectual property) and reputation (‘the company’s main assets’). The employee declares that he has carefully read the provisions of this undertaking, that he understands the results of this undertaking and agrees to what is stated herein, and that he has assessed for himself the advantages and disadvantages involved in entering into this undertaking. Therefore, the employee undertakes:

 

That during his employment with the company and for a period of twelve months thereafter, he shall not enter into a contract, set up, open or be involved in any way, directly or indirectly, whether as an employee, owner, partner, agent, shareholder, director, adviser or in any other way, in any business, occupation, work or any other activity that may reasonably include or be related to the use of the company’s main assets (as defined above).

 

That during the period of his employment with the company and for a period of twelve months thereafter, he shall not induce any employee of the company or any of its subsidiaries, its holding companies or its affiliates to terminate his employment with them.

 

5.                                      Ownership of inventions

 

The employee shall notify and deliver to the company, or to anyone appointed on its behalf, any information, improvements, inventions, formulae, processes, techniques, knowledge and information, whether it can be registered as a patent or not, which was done or thought up or put into practice or learned by the employee, whether on his own or jointly with others, during the employee’s employment with the company (including after work hours, at weekends or during a vacation) (all such information, improvements, inventions, formulae, processes, techniques, knowledge and information shall be defined hereafter as: ‘inventions’ or ‘the invention’), immediately after discovering them, receiving them or inventing them, as applicable. If the employee is unable for any reason whatsoever to deliver the invention on the date of giving the notice of the invention, the employee shall notify the company of the invention and give details in his notice of the date on which it will be delivered to the employer and the reason for not delivering the invention immediately, and subsequently, as soon as possible, the invention itself shall be delivered.

 

Giving the notice and delivering the inventions shall be done in writing, together with a detailed description of the invention and suitable documentation. The employee agrees that all of the inventions shall be the sole property of the company and its transferees and that the company and its transferees shall be the sole owners of all the patents and other rights relating to such inventions. The employee hereby assigns to the company all of his existing and future rights in such inventions. In order to remove doubt, it is hereby clarified that the lack of a negative answer from the company with regard to notice of an invention or of its delivery shall not be interpreted as a waiver of the ownership of an invention, and in any case the invention shall become the property of the company only.

 

10

 

The employee agrees with regard to all the inventions mentioned above to assist the company, or any person appointed on its behalf, in any appropriate manner, to receive and from time to time to carry out any act, including the implementation and registration of the inventions in any way, including by way of registration of patents for inventions as aforesaid in any country whatsoever, and to sign all of the documents that are required for filing and obtaining a patent for the inventions as aforesaid and for their implementation, as the company shall wish, including letters of assignment for the inventions as aforesaid to the company or persons or entities appointed by it.

 

The employee shall not be entitled, insofar as the aforesaid is concerned, to any pecuniary or other consideration in addition to what is stated in appendix A of this agreement or in addition to what is stated in any other special agreement or arrangement on this matter that are made in writing and signed by the company. Insofar as the aforesaid is concerned, no arrangement, communication or consent that is made orally or in writing shall have any effect, unless they are duly signed by the company.

 

6.General

 

The employee agrees that the provisions of this undertaking, which constitute an integral part of the terms of his employment, are reasonable and necessary in order to protect legitimate interests of the company with regard to the subject of this undertaking.

 

If any court of law determines that any provisions in this undertaking (including any sentence, paragraph or part hereof) is not valid or is unenforceable, then such provisions shall be regarded as if they were amended in such a way that the parts that were determined as aforesaid to be not valid or unenforceable will be struck out. The striking out as aforesaid shall apply only with regard to duties and requirements mentioned in the provision as aforesaid in the jurisdiction where the decision as aforesaid is given. Moreover, if it is determined that a certain provision that is included in this undertaking is too broad with regard to the periods of time mentioned therein, the geographic scope, an activity or issue, it shall be interpreted so that the aforesaid provision shall be limited and restricted with regard to the aforesaid characteristic so that the provision shall be enforceable to the greatest degree possible in accordance with the law applicable at that time.

 

The provisions of this undertaking shall remain fully valid even after the termination of the employment period between the company and the employee for any reason whatsoever. This undertaking shall not be used in any way to derogate from the employee’s undertakings and liability under any law.

 

	
 
    	
Signature:
    	
 /s/ Yiftach Roth
    

 

11Exhibit 10.5

 

[UNOFFICIAL TRANSLATION INTO ENGLISH]

 

Employment Agreement

 

which was made and signed in Jerusalem on January 8, 2017 (hereinafter: “the Agreement” and “the date of the Agreement” respectively)

 

Between:                                                                                             Brainsway Ltd.

of 19 Hartom St.,

Har Hotzvim, Jerusalem

hereinafter: “Brainsway”)

 

of the one part

 

And Between:                   Mr. Yaacov Michlin

ID: 014404677

12 Menuhin St., Rehovot

(hereinafter: “the CEO”)

 

of the second part

 

Whereas:                                          And Brainsway and the associated companies, as defined below, engage in development and manufacture of solutions for mental and neurological illnesses and disorders.

 

And whereas:                    Brainsway is a company traded on the Tel Aviv Stock Exchange, Ltd.

 

And whereas:                    Brainsway is desirous and has the legal authority to employ the CEO in the position of CEO (hereinafter: “the position”) in accordance with the terms of this agreement.

 

And whereas:                    The CEO has expressed his desire to work for Brainsway in the position and he declares that he the skills, the competencies and the experience required for fulfillment of the position and is desirous of working under the terms set forth in this agreement, and that there is no legal and/or other bar to his work in accordance with the provisions of this agreement.

 

And whereas:                    The parties wish to determine in this agreement the terms of the employment and work of the CEO and to determine the mutual rights and obligations of the parties.

 

Accordingly as agreed, declared and stipulated between the parties as follows:

 

1.                                                                                      General

 

1.1.                                                                            The preamble to this agreement shall be deemed an inseparable part thereof, and is equal to the remainder of the provisions of this agreement.

 

 

1.2.                                                                            The headings of the sections and/or clauses are for convenience of reading only and the clauses in the agreement will not be interpreted in accordance with them.

 

1.3.                                                                            This agreement also constitutes notice with regard to the terms of employment in accordance with the Notice to Employee Law (Terms of Employment) - 2002 and its regulations, and does not have the effect of detracting from any right accorded to the CEO at law.

 

2.                                                                                      Terms of Engagement and the Position of CEO

 

2.1.                                                                            Brainsway declares that it is a public company, lawfully incorporated, traded on the Tel Aviv Stock Exchange, Ltd.

 

2.2.                                                                            The CEO will be employed under this agreement starting on April 1, 2017 save if the parties have agreed otherwise in writing prior to this date (hereinafter: “the date of commencement of work”) in the position of CEO of Brainsway for an undetermined period of time.

 

2.3.                                                                            In his position, the CEO will manage all of the activity of Brainsway (including its subsidiaries in Israel and abroad (hereinafter: “the associated companies”).  The CEO will report to the Board of Directors of Brainsway, including by means of reports to the chairman of the Board of Directors or his deputy.

 

2.4.                                                                            The CEO declares and undertakes hereby that he has the skills and experience suitable for fulfillment of the position and that there is no other reason, including a bar at law, which may preclude him from fulfilling his position and all of his undertakings.

 

2.5.                                                                            It is clarified and agreed that all of the payments and the social benefits to which the CEO is entitled under this agreement will be paid and will be granted by Brainsway and/or Brain Research Services, Ltd, which is a wholly owned subsidiary of the Company (hereinafter: “Brain”) (Brainsway and/or Brain will be hereinafter called: “the Company”),  at the discretion of the Company.

 

3.                                                                                      Membership in the Board of Directors of Brainsway

 

3.1                                                                               Subject to the restrictions at law, if existing, the membership of the CEO in the Board of Directors of Brainsway shall remain valid until the termination of his current tenure as a member of the Board of Directors.

 

3.2.                                                                            Starting on the date of commencement of the work as defined above, and further to the provisions of clause 10.5 of the compensation policy (as defined below), and so long as this agreement is valid, the CEO will not be entitled to any additional compensation for his service as a director in Brainsway, beyond the compensation provided to him as the CEO under this agreement, and this without

 

 

detracting from the options granted to him as a director, which shall continue to apply and to vest as per their terms.

 

4.                                                                                      Duties of the CEO

 

4.1.                                                                            The CEO will make available to the Company his professional knowledge as required and related to his position, shall act to the best of his ability, his efforts and his skills, for performance of his position, and will carry out his position with dedication, decency and loyalty, in accordance with the directives which he shall receive from time to time from his supervisors.

 

4.2.                                                                            The CEO will be a Company employee only.  The CEO will not carry out any work or any service to any other party, for pay or without pay, and will not be engaged, directly or indirectly, with any business, undertaking, services, position or occupation, without the consent of Brainsway in advance and in writing.  Notwithstanding that stated, it is agreed hereby that the CEO will be permitted to continue to serve as director in one additional public company (currently Satcom Systems Ltd.) and to continue to serve as director in a number of companies related to his previous position at Yissum, and this so long as conflict of interest does not exist between his service as director in the companies as stated and performance of his undertakings towards the Company.

 

4.3.                                                                            The CEO undertakes to act in accordance with the obligations of confidentiality and non-compete and the obligations with regard to safeguarding and protection of the intellectual property of the Company and the associated companies, all as specified expansively in clauses 12 and 13 to this agreement.

 

4.4.                                                                            The Company will provide to the CEO, for performance of his work, the conditions required for this position, and computing devices which include a laptop, a tablet, hardware, software, email and so forth (hereinafter: ‘‘computing devices’’).  The computing devices are property of the Company and are intended for performance of the work of the CEO in the Company.  The CEO is requested to sign upon the principles of the policy of the Company in this matter which are attached as Appendix B to this agreement.

 

5.                                                                                      Work Hours

 

5.1.                                                                            The CEO will be engaged in a full-time position.  In general, the work is carried out on Sunday through Thursday.  The ordinary work day of the Company is nine hours.  The Saturday is the weekly day of rest for the CEO and CEO will not work on Saturday or Israeli holidays.

 

5.2.                                                                            The CEO is aware that the work relations with him are built on trust and work in flexible hours, the position and the requirements of job will require the CEO to work beyond the ordinary hours of work.

 

 

5.3.                                                                            Notwithstanding that stated above, the CEO is aware that taking into account the fact that he is employed under this agreement in the position of CEO, which requires a special measure of personal trust.  Work and Rest Hours Law - 1951, or any law which shall be enacted or shall replace it (‘‘Work Hours Law’’) does not apply to his employment, and he shall not be entitled to payments in accordance with the Work Hours Law.  For the sake of removal of doubt, it is clarified hereby that the wage of the CEO includes therein a component of all of the payments which would be due to him were the provisions of the work hours law to apply to him.

 

6.                                                                                      The Consideration

 

6.1.                                                                            In consideration for fulfillment of the entirety of the undertakings of the CEO under this agreement, and subject to receiving approval of the general assembly of shareholders of Brainsway, the Company shall pay to the CEO a gross monthly wage in an amount of NIS 71,108 per month, and this as specified in the sample pay stub attached as Appendix C to this agreement (hereinafter: ‘‘the wage’’).  The wage will be paid to the CEO up to the ninth day of each month after the month of work.

 

6.2.                                                                            The CEO will bear all of the tax liabilities in respect to his wage and all of the ancillary benefits and conditions provided to him as specified in this agreement, with the exception of bonuses for which it is stated explicitly that the Company shall bear the tax burden.  The Company is responsible for deducting at source all of the amounts which it must deduct that at source in accordance with applicable law.

 

7.                                                                                      Ancillary Conditions

 

Subject to approval of the general assembly of shareholders of Brainsway, the CEO will be entitled to the following conditions:

 

7.1.                                                                            Vehicle Use - the Company shall provide a vehicle for the CEO, the model agreed between the Company and the CEO at a value of up to NIS 200,000.00 (“the vehicle”).  The CEO undertakes to drive carefully, and to care for the vehicle.  The Company will bear all of the fixed and variable costs of the vehicle, including fuel and oils, licensing costs, insurance and various repairs, parking, toll roads, washing and cleaning and so forth.  The Company will also bear the tax in respect of the use of the vehicle or any other levy or obligatory payment.  The CEO will be exclusively responsible for any traffic infraction which he performs while using the vehicle and/or any fine imposed upon the Company during the use of the vehicle.  In such instance, the CEO will sign upon an affidavit and/or any other document confirming the performance of the violation by him.  Every three years or as needed, the Company will replace the vehicle with a new vehicle.  The CEO will return the vehicle to the Company and he shall not have any rights to withhold the vehicle, at the end of 30 days from the date upon which he ceased

 

 

traveling to facilities of the Company on a regular basis and/or to fully carry out his work under the terms of this agreement).

 

7.2.                                                                            Mobile phone expenses - the Company will bear the cost of maintenance and use of a mobile phone of the CEO and will bear the cost of the taxes in respect of the use of the phone or any levy or other obligatory payment.

 

7.3.                                                                            Refund of expenses - The CEO will be entitled to a full refund of expenses, including taxes as needed, which relate to fulfillment of his position and in respect of travel, accommodations and per diem expenses as shall be in the framework of his position in Israel and overseas, as against receipts, and this in accordance with the policies of the Company as updated from time to time.

 

7.4.                                                                            Options - Options shall be granted to the CEO for purchase of shares of Brainsway as follows:

 

Options for the purchase of 566,262 shares of Brainsway with a nominal value of NIS 0.04, which constitute, as of the date of the agreement, 3.6% of the issued and paid up share capital of Brainsway upon full dilution (“full dilution” at a certain date shall mean assuming the exercise of all of the options which Brainsway has allotted and which have yet to be exercised or expired at such date), subject to the terms of vesting and at the exercise price per share and additional terms as determined in Appendix D to this agreement (hereinafter: “the options”).  Other terms and restrictions of the options beyond that stated in Appendix D shall be determined by the Board of Directors at its exclusive discretion, in accordance with the terms of the compensation policy of Brainsway as amended from time to time (hereinafter: “compensation policy”) and future resolutions of the Board of Directors and subject to the terms of the grant letter which shall be signed by the CEO.  It is clarified that the granting of options in accordance with this clause is contingent upon approval of the Tel Aviv stock exchange with regard to the registration for trading of the shares which shall arise from exercise of the options granted to the CEO.

 

7.5.                                                                            Bonuses - The CEO will be entitled to receive bonuses for attainment of targets determined from time to time by the Board of Directors and in accordance with the terms of the compensation policy.  Furthermore, if the Company carries out a merger and purchase transaction or a successful issue of Brainsway, as per the definition thereof in the compensation policy of Brainsway, as it shall shall be from time to time (hereinafter: “special events”,  and each of the previous: “special event” and “compensation policy”, respectively) during the first two years of the service of the CEO (meaning from the date of commencement of work) the CEO will be entitled to any grant in respect of a special event as stated, in accordance with the terms of the compensation policy and at a total gross amount of NIS 1,000,000 (one million).  The CEO will bear all of the taxes and the obligatory payments which shall apply in respect of bonuses as stated.

 

 

8.                                                                                      Annual Vacation, Sick Pay and Recuperation

 

Annual Vacation:

 

8.1.                                                                            The CEO shall be entitled to annual vacation days as per the Annual Vacation Days Law - 1951 (hereinafter: “the annual vacation days at law” and “the annual vacation days law”, respectively).  The Company will grant the employee additional vacation days (hereinafter: “the contractual vacation days”) such that together with the vacation days at law, they shall reach a total of 22 days per year.

 

8.2.                                                                            The dates of the vacations of the CEO will be coordinated at least seven days in advance with the Chairman of the Board of Directors of Brainsway or his deputy.  The Company shall be entitled to determine, from time to time as it deems fit, concentrated vacation days which the CEO shall be required to take.

 

8.3.                                                                            The vacation days which the CEO shall utilize will be deducted from the vacation days available at law and once these have been utilized in full, they shall be deducted from the contractual vacation days.  The CEO will, to the best of his ability, utilize the annual vacation days at law in the same calendar year as they were granted to him.

 

8.4.                                                                            The CEO will be entitled to accumulate the contractual vacation days for one work year.  Accumulation of the vacation days per the law will be possible in accordance with the annual vacation days law.

 

The contractual vacation days may not be redeemed.  The vacation days at law may be redeemed upon termination of employer-employee relations in accordance with the annual vacation days law and subject to requirements of the law and the policy of the Company as shall be from time to time, up to a maximum of 22 vacation days.

 

Sick Pay:

 

8.5.                                                                            The CEO will be entitled to fully paid sick days as against presentation of medical approvals, and in accordance with the provisions of the law.  Notwithstanding that stated above, the CEO will be entitled to full payment of his monthly wage for sick days from the first sick day, and subject to the number of accumulated sick days available for him.  In any event, unused accumulated sick days may not be redeemed.

 

Recuperation Days:

 

8.6.                                                                            The CEO will be entitled to recuperation days at law.

 

 

9.                                                                                      Pension Insurance

 

9.1.                                                                            The Company will deposit on behalf of the CEO into a pension fund, provident fund or managers insurance at the discretion of the CEO, or a combination of these, the rates of the deposits as specified below:

 

9.1.1.                                                                  Company share in provident fees.

 

9.1.1.1.                                                        The share of the Company in the provident fees shall stand at 6.5% of the wage.

 

9.1.1.2.                                                        Payment as stated in Clause 9.1.1.1 (“Company share in provident fees”) to an insurance fund or a provident fund which is not a pension fund, will include the payment of the Company for purchase of coverage in the event of loss of work capacity at the rate required to ensure 75% of the wage (“LOWC Policy”) when in any event, the rate of provision of the Company for the provident part alone shall not be less than 5% of the wage.

 

9.1.1.3.                                                        To such extent as an increase shall be required in the cost due to cost of the LOWC Policy, beyond the share of the Company in the provident fees as stated, the Company shall pay in respect of the LOWC Policy together with the share of the Company in the provident fees as stated, not more than 7.5% of the wage, in any event.

 

9.1.2.                                                                  The share of the CEO in the provident fees.

 

9.1.2.1.                                                        The share of the CEO in the provident fees shall be 6% of the wage.

 

9.1.2.2.                                                        The CEO grants his consent for the withholding from his salary of his share in the pension arrangement, as specified above.

 

9.1.3.                                                                  Deposits instead of severance pay.

 

9.1.3.1.                                                        In respect of severance pay - the Company shall make a provision in an amount equal to 8.33% of the wage.

 

9.1.3.2.                                                        It is agreed that there shall apply to the pension deposits as stated above the general approval with regard to payments of employers to a pension fund and to insurance fund instead of severance pay, the text of which is attached hereto as an inseparable part of this agreement and mark Appendix A to this agreement (hereinafter “the general approval”) and/or any other approval, which shall come in its stead.  For the sake of removal of doubt, the provisions of the Company in the framework of the pension arrangement in respect of severance pay shall come in the stead of the entirety of the severance pay if this shall be due to the CEO, and this in accordance with Article 14 of the Severance Pay Law-1963, and in accordance with the general approval and/or any other approval, which shall come in its stead and/or under Clauses 7-9 of the Expansion Order (combined version) for Compulsory Pension-2011.

 

 

9.1.4.                                                                  The parties confirmed that they understand that the amounts provided as stated above are higher than those determined in the general approval, which has not yet been revised and/or the Expansion Order for Compulsory Pension, and accordingly, they agree that, that stated in Article 14 of the Severance Pay Law shall apply with the understanding that the terms of the general approval and/or that stated in the Expansion Order apply also in the event of provisions which are higher than those determined in the general approval.

 

9.1.5.                                                                  It is clarified hereby that the Company waives its rights to a return of the funds which it paid to the pension arrangement, save if the entitlement of the CEO to severance pay shall be denied in accordance with the provisions of Articles 16 or 17 of the Severance Pay Law, in the event that the entitlement is denied, or if the CEO withdraws the funds from the policy other than for an entitling event.  For this matter “entitling event”: death, disability or retirement at an age of 60 or more, all in accordance within subject to the general approval.

 

10.                                                                               Continuing Education Fund

 

10.1.                                                                     The Company will pay on a monthly basis into a continuing education fund selected by the CEO (“continuing education fund”) a total in NIS equal to 7.5% of the monthly wage.

 

10.2.                                                                     Additionally, the Company shall deduct from the monthly wage of the CEO, 2.5% and transfer this to the continuing education fund as the share of the CEO in the continuing education fund.

 

10.3.                                                                     The amount to which the CEO is entitled under Clause 10.1 above, will be deposited by the Company into the continuing education fund.

 

11.                                                                               Termination of the Agreement

 

11.1.                                                                     This employment agreement is for an indeterminate period.  Either party may bring this agreement to an end by advanced notice in writing to the counter party in accordance with the law, but not less than an advanced notice period of two months in the first year from the date of commencement of work and four months thereafter.

 

11.2.                                                                     In the period of the advanced notice, the CEO will be required to carry out his work fully and properly, and to transfer his position to a replacement who shall be determined, as shall be necessary.

 

11.3.                                                                     The Company is entitled to waive the work in practice in the period of the advanced notice, in whole or in part, continuously or alternately.

 

 

11.4.                                                                     Notwithstanding that stated above, it is hereby agreed that the Company is entitled to suspend the CEO and/or to cease the work of the CEO at any time immediately, and to immediately terminate the work relations (including during the course of the period of the advanced notice for resignation or dismissal), without the need for notice in writing and without any monetary consideration whatsoever in respect of failure to provide advanced notice, in whole or in part, and this if the CEO shall have made a fundamental breach and not rectified within 14 working days of having received a caution thereupon and/or if the Company shall be entitled to do so at law, and in anyone of the following instances:  (1) shall have carried out a criminal violation involving moral turpitude; (2) has commenced proceedings for declaration of bankruptcy or has consented to submission of an application for such proceedings against him or was declared by a competent court as bankrupt or insolvent.

 

11.5                                                                        Upon termination of the employment for any reason, the CEO must return to the Company any assets, equipment, document and information in his possession and which was provided to him during the course of or due to his work under this agreement and the CEO shall not have any right to withhold these or any other rights.

 

12.                                                                               Confidentiality and Non-Competition

 

12.1.                                                                     In this Clause 11, the Company, including the shareholders and officers, subsidiaries, sister corporations and associated corporations, including their shareholders and officers, suppliers, customers, partners and investors, including their shareholders and officers.

 

12.2.                                                                     The CEO declares that he is aware and agrees that during the course of his work and in the framework of the fiduciary relations, he is exposed and will be exposed to professional-commercial information of great value with regard to the business affairs of the Company and various commercial ties and particularly with regard to the investment of funds of the Company and of additional investors, including the local or overseas partners (hereinafter: “the activity of the Company”).  This information is the exclusive property of the Company and its disclosure to any party or any use thereof by the CEO may cause grave damage to the Company.

 

12.3.                                                                     Accordingly, the CEO hereby undertakes to maintain the professional and commercial secrets of the Company, its subsidiaries and associated companies and not to transfer, directly or indirectly, for consideration or without, its professional and commercial secrets and those of its subsidiaries and associated companies, other than in the framework and for the purpose of performance of his work at the Company exclusively.

 

12.4.                                                                     Furthermore, the CEO undertakes not to disclose, to display or to deliver, during the period of employment at the Company and/or thereafter, to any person or body, any commercial secrets and/or others of the customers of the Company to

 

 

which the CEO is exposed in the course of his work at the Company and or due to his work at the Company, and any information connected directly or indirectly to the property, business, affairs, customers, suppliers and the persons or bodies involved with the Company or its customers or those in contact with them, and including, but without detracting from the generality of that stated above, procedures, prices, calculations, terms of engagement with customers and suppliers, diagrams, documents and secrets and details or information regarding an investor in the Company, and this whether the secrets or the associated information have reached the CEO as a result of his employment by the Company or in any other manner and provided that they did not become public information.

 

12.5.                                                                     Without detracting from the generality of that stated above, the CEO undertakes to adapt any reasonable means to highly safeguard any document, program or information held by him in connection with his employment of the Company, belonging to the Company or its clients (hereinafter:  “the information”) in order to prevent its viewing by any other person who the Company or any of its customers have not permitted to do so, and not to make any use of the information as stated above, other than for the purposes for which the information was provided to him.

 

12.6.                                                                     The CEO will comply with any demand of the Company and or its clients with regard to the adapting of additional means of security to those which he has adapted.  In the event of any problem in connection with the information, the CEO will notify the Company immediately upon the occurrence.  Immediately upon termination of his work at the Company and/or termination of provision of services to a customer of the Company, the CEO will deliver to the Company all of the information in his possession.

 

12.7.                                                                     The CEO hereby undertakes not to work and not to be engaged, directly or indirectly, for consideration or without, himself or by means of a party on his behalf, as an employee, adviser, partner, contractor, distributor, shareholder and  in any other capacity-in any business, position, work, occupation and/or other activity whatsoever which competes directly with the activity and/or the business of the Company, its subsidiaries and associated companies and not to incite employees and/or those employed by the Company to leave their work, not to employ them, directly or indirectly, not to assist them in finding work with competitors of the Company and its subsidiaries, and this during the course of his work at the Company and for a period of 12 months from the date of its termination.

 

12.8.                                                                     The CEO undertakes not to refer suppliers and/or former suppliers of the Company and/or the subsidiary and associated companies to suppliers and/or former suppliers and not to encourage them to sever their commercial contact with the Company, to compete with it, to take commercial information of the Company, to engage with any third parties or whatsoever, directly or indirectly including competing parties, and this during the course of the work at the

 

 

Company and for 12 months from the date of its termination.  And all-directly or indirectly, himself or by means of a party on his behalf, at his initiative or at the initiative of some other, for consideration or without, whether an employee, advisor, investor, partner, distributor, shareholder and in any other capacity and/or manner.

 

13.                                                                               Intellectual Property

 

13.1.                                                                     In this clause 13 and in clause 14, the Company, including its shareholders and officers, subsidiaries, sister or associated companies, including their shareholders and officers, suppliers, partners, investors, including their shareholders and officers.

 

13.2.                                                                     It is hereby agreed that the rights, including the intellectual property rights, to any invention, idea, creation, information, development, discovery, process, technological method, including any innovation, addition, improvement or derivative of an invention, idea, work product, creation, information, discovery, process, technological method, as stated (hereinafter - “invention”) which the CEO, whether independently or in collaboration with others, will discover, develop or invent or create, related to his work or in the field of his professional occupation with the Company, whether such rights may be registered at law or not (hereinafter - “inventions in service of the Company”), do and shall in the future, belong exclusively to the Company.  The CEO shall not have any contentions and/or claims with regard to inventions in service of the Company and he hereby assigns to the Company any right and/or contention to such extent as exist or shall exist, in connection with inventions in service of the Company.  Without detracting from that stated, the CEO hereby explicitly waives any rights or contention or demand in connection with consideration or royalties in respect of inventions in service of the Company and/or the use of thereof including the right and/or contention under Article 134 of the Patent Law - 1967.

 

13.3.                                                                     If the Company decides to protect an invention by means of registration of any right in connection with the invention in service of the Company, in Israel or abroad, the CEO will cooperate with the Company, including signature upon documents and delivery of any material or information as required for submission of the application and performance of the registration.

 

13.4.                                                                     That stated in clauses 13.1 and 13.2 above shall apply also to inventions as defined in 13.1 above which the CEO shall discover, develop, invent or create, independently or with others, within a period of one year from the date of the termination of the engagement between him and the Company for any reason whatsoever (or a shorter period as shall be provided at law) if the CEO will use and utilize information or material which came to his possession or his knowledge in the framework of his work at the Company.  The parties hereby agree that all of the rights including the rights to payments for inventions specified in clause 13.3, belong to the Company.  The CEO confirms hereby explicitly that he does not nor

 

 

shall not have any rights, demands or claims in connection with the inventions in question in clause 13.3.  This includes a right and/or claim for payment and/or royalties.  Without detracting from that stated, the CEO waives any rights or contention (as may be, to receive consideration under Article 134 of the Patent Law).

 

13.5.                                                                     Without detracting from any law, the CEO hereby undertakes to inform the management of the Company in writing at the earliest possible time, of any invention as defined in clause 13.1 above, which he shall discover, develop, invent or create during the course of his employment in the Company and including one year after its termination or a shorter period as provided at law, or related to his work or his professional field of engagement, regardless of whether the CEO believes that that stated in the provisions of clause 13.1, 13.2 or 13.3 above shall apply to such invention.

 

13.6.                                                                     In addition, the CEO hereby waives as towards the Company any moral rights he may have in an invention as defined in clause 13.2 above.  For this matter, “moral right” as defined in the Copyright Law - 2007.

 

14.                                                                               Declarations of the CEO

 

The CEO declares and confirms that:

 

14.1.                                                                     His undertaking to maintain confidentiality, restriction of competition and safeguarding of intellectual property under this contract above, is fair, reasonable and proportionate, and is intended principally to defend the secrets of the Company and its secret information, which are the essence of its business and commercial advantage which may be protected, and in which significant capital was invested.

 

14.2.                                                                     Breach of his undertakings above - shall be in contravention to the fiduciary relation and the special loyalty which exists between the parties as employee and employer, to proper conduct of commerce, and to the duty of good faith and decency between the parties, shall harm the business of the Company, and constitutes fundamental breach of this contract and of commercial secrets, commercial contact, secret information and protected interests of the Company.

 

15.                                                                               Miscellaneous Provisions

 

15.1.                                                                     This Agreement regulates the relations between the Company and the CEO and determines exclusively the terms of the employment of the CEO by the Company.

 

15.2.                                                                     This Agreement is personal and special and accordingly there shall not apply to the relations between the companies the general and/or special collective agreements and/or their appendices, or other agreements, which are signed from

 

 

time to time between the General Workers’ Union and/or any other representative employee union.

 

15.3.                                                                     For the sake of removal of doubt, it is clarified and agreed hereby that in any event of interpretation of this Agreement, all of its conditions must be read and certain components may not be separated from the consideration due to the CEO in consideration for his work, from other components.  The CEO declares that he has thoroughly examined the entirety of the conditions in this Agreement and has found them satisfactory.

 

15.4.                                                                     Any notice by any of the parties to the counter party by registered post shall be deemed to have been received by the other party 72 hours after its dispatch as mentioned.  The addresses of the parties for purposes of this agreement are as specified in the preamble to this agreement.

 

In witness whereof the parties have signed in the place and at the time above:

 

	
/s/ Dr. David Zacut
    	
 
    	
/s/ Yaacov Michlin
    
	
Brainsway Inc.
    	
 
    	
CEO
    
	
 
    	
 
    	
 
    
	
Name of Signatory: Dr. David   Zacut
    	
 
    	
 
    
	
Position:    Chairman of the Board
    	
 
    	
 
    

 

Brain hereby confirms that the terms of this agreement are known and acceptable to it and bind it to such extent that they relate to it.

 

	
BRAIN RESEARCH SERVICES LTD.
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
Name of Signatory: Dr. David   Zacut
    	
 
    
	
Position: Chairman of the Board
    	
 
    
	
Date 08/01/17
    	
 
    

 

Attached:

 

Appendix A - General Confirmation Approval regarding payments of employees to insurance fund and in the stead of severance pay (according to the Severance Pay Law - 1963).

 

 

Appendix B - Usage Rules for computing devices of the Company.

 

Appendix C - Sample Pay Stub

 

Appendix D - Options

 

 

Appendix A - General Confirmation Approval regarding payments of employees to insurance fund  in the stead of severance pay (according to the Severance Pay Law - 1963).

 

By Virtue of my Authority under Article 14 of the Severance Pay Law-19631 (hereinafter: “the law”) I confirm that the payments which an employer made starting on the date of publication of this approval, on behalf of his employees to a comprehensive pension fund in a stipend provident fund which is not an insurance fund as per the definition thereof in the Income Tax Ordinance (rules for approval and conduct of provident funds) - 19642 (hereinafter: “pension fund”), or to Managers Insurance which includes the possibility of a stipend or a combination of payments to a stipend plan and a non-stipend plan in an insurance fund as mentioned (hereinafter called “insurance fund”), including payments made in combination of payments to an insurance fund, whether the insurance fund has a stipend program or not (“employer payments”) shall come in the stead of severance pay due to the employee as mentioned in respect of the wage from which the aforementioned payments were made for the period which was paid (hereinafter: “the exempt wage”), and provided that all of the following were fulfilled:

 

1.)                                                                                  Employer payments to the pension fund are not less than 14 1/3% of the exempt wage or 12% of the exempt wage if the employer pays on behalf of the employee.  In addition also payments for supplementation of Severance pay to a severance provident fund or an insurance fund in the name of the employee at a rate of 2 1/3% of the wage which is exempt.  If the employer shall not pay in addition to the 12% also the 2 1/3% as stated, the payments shall come in the stead of 72% of the Severance pay of the employee only.

 

B.)                                                                                To insurance funds which are not inferior to one of the following:

 

13 1/3% of the exempt wage, if the employer additionally pays on behalf of his employee payments to insure monthly income in the case of lost capacity for work, in a program approved by the supervisor of Capital Markets, Insurance and Savings in the Ministry of Finance, at a rate required to insure 75% of the exempt wage at least or a rate of 2 1/2% of the exempt wage, the lower of these (hereinafter: “payment for loss of work capacity insurance”).

 

2.)                                                                                  11% of the exempt wage in the event that the employer additionally paid into loss of work capacity insurance and in such instance the payments of the employer shall come in the stead of 72% of the Severance pay of the employee only.  If the employer paid in addition also payments to supplementation of the Severance pay into a severance provident fund or an insurance fund in the name of the employee at a rate of 2 1/3% of the exempt wage, the payments of the employer shall come in the stead of 100% of the Severance pay of the employee.

 

2.)                                                                                  Not later than three months from the start of performance of the payments of the employer, a contract in writing was effected between the employee and the

1                                                                                                                                           Law Gazette 1963, page 136

2                                                                                                                                           Law Book 1964, 1302 2

 

 

employer containing - the consent of the employee to the arrangement under this approval in the format specifying the payments of the employer and the pension fund and the insurance fund, as the case may be.  Such contract will also include the format of this approval.

 

Waiver of the employer in advance of any right he may have to a return of the funds of his payments, unless the right of the employee to Severance pay was denied in a judgment under Articles 16 or 17 of the law and in the event that it was denied or the employee withdrew funds from the pension fund or the insurance fund other than due to an entitling event.  In this matter, “entitling event” - death, disability or retirement at the age of 60 or thereafter.

 

3.)                                                                                  Nothing in this approval has the effect of detracting from the right of the employee to Severance pay under the law, collective agreement, Expansion Order or employment contract in respect of wage beyond the exempt wage.

 

The Severance Pay Law of the 1963

 

June 9, 1998

 

Eliyahu Yishai

Labor and Welfare Minister

 

 

Appendix B - Usage Rules for computing devices of the Company

 

Dear Employee, for your information below, the usage policy in computing devices (hereinafter: “computing devices usage policy”).  Please read it and sign at the bottom of the page to indicate your consent.

 

1.                                                                                      The Company has provided you for work purposes computer devices which include, a computer, hardware, software, email, telephone and so forth (hereinafter: “computing devices”).  The computing devices are the property of the Company and for the safeguarding thereof you are required to act per the following instructions:

 

1.1                                                                               Hardware - do not install upon the computing devices, hardware or connect hardware to the computing devices without approval of your supervisor or of the computing staff.  Including, do not connect an external hard disk, disk on key, camera, cellular phone or any other type of equipment.  Additionally, do not make use of CDs which are not of the Company or are not related to activity of the Company.

 

1.2                                                                               Software — do not install software on the computing devices without approval of your supervisor or the computing staff.  Including, do not install software for the processing of pictures, games, chat programs, internet toolbars or any other program.

 

1.3                                                                               Files - do not save upon the computing devices private files which are not related to the Company and including, do not save upon the computing devices pictures or private video.

 

1.4                                                                               In any question or inclarity regarding these instructions, you can contact your direct supervisor or the computing staff of the Company.

 

2.                                                                                      However, the Company is aware of your need to make private use of the computing devices.  These uses permitted subject to the following rules:

 

2.1                                                                               Electronic Mailbox — was provided to you for your use by the Company solely and exclusively for your work.  You are not permitted to make use of it for personal activity unrelated to your work and including correspondence with friends and family by means of the email box provided by the Company.

 

2.2                                                                               To such extent as you desire to send or receive private email during work hours and/or at work, you must do so by means of an external private email (gmail, hotmail and so forth).  As stated above, it is forbidden to save files which you received by means of an external email address onto the computing devices.

 

 

2.3                                                                               You are entitled to make use of the internet for private needs at a reasonable scope of time and without this prejudicing your function at work, subject to the rules which were determined in the Company policy.

 

3.                                                                                      For purposes of safekeeping of the computing devices and protecting the legitimate interests of the Company and the Company, the Company makes use of monitoring technologies and blocking and restriction of use, the scope and details of which are set out in the computing device usage policy.  The use of the monitoring technologies enable the Company to read data and content of the professional correspondence of its employees including correspondence carried out by means of the electronic mail address provided by the Company to its employees.

 

4.                                                                                      The monitoring is not intended to harm the privacy and in general the Company is uninterested in reading the correspondence conducted in the email accounts which it provides.  However, the Company is entitled to read professional correspondence and will act in such manner to such extent allowed by law in circumstances where this is necessary, unavoidable and required for protecting the legitimate interests of the Company.

 

5.                                                                                      If and to such extent as personal correspondence will be found in the email account provided by the Company in contravention to the specific provisions set out above, the Company shall be able to read such correspondence, under special and extraordinary circumstances only, of serious danger of harmful or illegal activity on your part and subject to receiving your consent.

 

6.                                                                                      You are requested to sign below to indicate your consent to that stated above and to the computing devices usage policy of the Company.

 

Confirmation

 

I, the undersigned confirm that I have read this document thoroughly, I have received all of the clarifications and explanations I requested, I consent to all that stated therein and undertake to act as stated and to comply with the policies of the Company in everything related to use of the computing devices.

 

	
Yaacov Michlin
    	
014404672
    	
/s/ Yaacov Michlin
    	
8/1/17
    
	
Employee Name
    	
Identity Number
    	
Signature
    	
Date
    

 

 

Appendix C Sample Pay Stub

 

 

Appendix D Terms of Options

 

Date of the Granting of Options:

 

The date of commencement of work (as defined in the agreement)

 

Terms of Vesting:

 

The options will vest over a period of four years starting on the date of commencement of work (“date of commencement”), and provided that at the relevant date of the vesting the CEO is an employee of the Company:  0.9% of the issued and paid-up share capital of Brainsway on the basis of full dilution correct as of the date of the agreement (meaning, 25% of the total of the options) shall vest at the end of one year from the date of commencement and the remainder in equal parts (meaning, 0.225% of the issued and paid-up share capital of Brainsway on the basis of full dilution as of the date of the agreement) shall vest upon the passage of every three months thereafter.

 

Exercise Price per Option:

 

A premium of 20% over the fair market value as specified in the compensation policy (as per the definition thereof of Clause 7 of this agreement) as of 5.1.2017 (meaning, a measure of 30 days previous, in accordance with that stated in the compensation policy, including Clause 9.2.3 of the compensation policy).

 

Acceleration:

 

The vesting of the options will be accelerated as follows, and all provided that at the time of the acceleration as stated the CEO as an employee of the Company:  If over the course of a period of two years starting on the date of the granting of the options, Brainsway shall carry out  transactions constituting a special event, as defined in the agreement, then immediately prior to completion of the special event, the options shall vest as follows:

 

(1) In the event of a merger and acquisition transaction-all of the options granted to the CEO will vest or, (2) in the event of a successful issue-options will vest at a rate of 50% of the total options which would not have matured up to such date of completion of the successful issue where if not for this acceleration (meaning, 50% of the options which had not yet matured).  If at the end of a period of two years from the date of the granting of the options, Brainsway shall carry out a transaction constituting a special event, then immediately prior to the date of completion of the special event, all of the options granted to the CEO shall vest.

 

Termination of Position:

 

In the event of termination of the position of a CEO as CEO or submission of advance notice of termination of the employment agreement (the earliest of these) at the date of completion as stated (the end of the advance notice period save if the employer - employee relations terminated earlier), all of the options which were alloted to the CEO and had not vested by such dates shall

 

 

be canceled and the remainder of the options which were alloted and which vested and may be exercised up until such date of termination as stated, shall be exercisable within three months of the date of termination as stated but not later than the date of their expiry, and all subject to the provisions above with regard to acceleration of the vesting of the options.

 

Notwithstanding that stated above, in the event of termination of the employment of the CEO by the Company in exceptional circumstances as stated and Clause 11.4 of the agreement, all of the options issued to the CEO and which have not yet been exercised shall immediately expire (whether they have vested or not).

 

In the event of death or disability of the CEO, the CEO or his successor or his estates (as the case may be) shall have the right to exercise the options having vested until such point, for one year from the date of the death and/or disability, as the case may be, but not later than the date of their expiry.

 

Period of Exercise, Date of Expiry of Option Deeds:

 

Subject to termination of the position as stated above, the CEO will be entitled to exercise the options of eight years from the date of their granting.  At the end of eight years from the date of their granting, all the unexercised options shall expire.

 

Registration for Trading:

 

The options shall not be registered for trading on the stock exchange.  The shares which shall arise from exercise of the options shall be registered in the register of shareholders of Brainsway in the name of a company for registration, and shall be registered for trading on the stock exchange, subject to approval of the latter.  These shares shall be, starting on the date of their allotment, equivalent in their value for all intents and purposes to ordinary shares with a nominal value of NIS 0.04 each, existing in the share capital of Brainsway.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]